Beyond premature apnea pauses: congenital myotonic dystrophy type 1

被引:0
|
作者
Segura, Patricia del Olmo [1 ]
Delgado, Carolina Sole [2 ]
del Val, Elena Martinez [3 ]
机构
[1] Hosp Fdn Alcorcon, Residente Pediat, Madrid, Spain
[2] Hosp Fdn Alcorcon, Dept Neonatol, Madrid, Spain
[3] Hosp Fdn Alcorcon, Dept Neuropediat, Madrid, Spain
来源
ANDES PEDIATRICA | 2024年 / 95卷 / 05期
关键词
Newborn; Apnea; Myotonic Dystrophy; Genetic Anticipation; Premature Newborn;
D O I
10.32641/andespediatr.v95i5.5092
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Congenital myotonic dystrophy type 1 (DM1) is a rare entity that can pose a diagnostic challenge, especially if other processes such as prematurity coexist. Objective: to describe the typical presentation of congenital DM1 and thus increase diagnostic suspicion. Clinical Case: A 29-week preterm female newborn who required non-invasive mechanical ventilation until 41 weeks postmenstrual age; she presented with apnea requiring manual ventilation with a self-inflating bag and cardiac massage. Initially, it was attributed to prematurity, but on physical examination, hypotonia, hyporeflexia, bilateral Achilles tendon retraction, facial diplegia, and weak sucking were confirmed. These characteristics, together with the respiratory compromise, suggested a possible congenital neuromuscular disease. The patient's history included infertility in the mother and polyhydramnios during gestation. The examination of the mother showed clinical myotonia, later confirmed by electromyogram, which suggested congenital myotonic dystrophy. This was confirmed genetically, finding 2000 CTG copies in the newborn and 833 in her mother. Conclusions: Apneas and respiratory compromise in a hypotonic and weak newborn are a frequent manifestation of this disease. The presence of myotonia in the mother of a newborn with suspected neuromuscular disease should lead us to think of congenital DM1. This case highlights the importance of an exhaustive anamnesis and physical examination of the patient and her mother as key elements in the etiological diagnostic orientation.
引用
收藏
页码:608 / 612
页数:5
相关论文
共 50 条
  • [31] Synaptic protein dysregulation in myotonic dystrophy type 1 Disease neuropathogenesis beyond missplicing
    Hernandez-Hernandez, Oscar
    Sicot, Geraldine
    Dinca, Diana M.
    Huguet, Aline
    Nicole, Annie
    Buee, Luc
    Munnich, Arnold
    Sergeant, Nicolas
    Gourdon, Genevieve
    Gomes-Pereira, Mario
    RARE DISEASES, 2013, 1 (01)
  • [32] Sleep disturbances in myotonic dystrophy type 2: A comparison with myotonic dystrophy type 1 and healthy controls
    Tieleman, A. A.
    Knoop, H.
    van de Logt, A.
    Bleijenberg, G.
    van Engelen, B. G. M.
    Overeem, S.
    NEUROMUSCULAR DISORDERS, 2009, 19 (8-9) : 645 - 645
  • [33] A patient with neurofibromatosis type 1 and myotonic dystrophy type 1
    Esra, Serdaroglu
    Ceren, Gunbey
    Banu, Anlar
    NEUROLOGY ASIA, 2022, 27 (02) : 503 - 506
  • [34] A Novel Case of Overlapping of Myotonic Dystrophy Type 2 and Bethlem Congenital Muscular Dystrophy
    Chalia, Mayur
    Bandyopadhyay, Sankar
    NEUROLOGY, 2019, 92 (15)
  • [35] Imaging of the thymus in myotonic dystrophy type 1
    Mignarri, Andrea
    Gentili, Francesco
    Masia, Francesco
    Genua, Angelo
    Cenciarelli, Silvia
    Brunori, Paola
    Mazzei, Maria Antonietta
    Malandrini, Alessandro
    Federico, Antonio
    Mazzei, Francesco Giuseppe
    Dotti, Maria Teresa
    NEUROLOGICAL SCIENCES, 2018, 39 (02) : 347 - 351
  • [36] Pain in Myotonic Muscular Dystrophy, Type 1
    Carter, Gregory T.
    Jensen, Mark P.
    Hoffman, Amy J.
    Stoelb, Brenda L.
    Abresch, Richard T.
    McDonald, Craig M.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2008, 89 (12): : 2382 - 2382
  • [37] Cardiac abnormalities in myotonic dystrophy type 1
    Finsterer, J
    Stöllberger, C
    AMERICAN HEART JOURNAL, 2004, 148 (06)
  • [38] Molecular biomarkers in myotonic dystrophy type 1
    Slipsager, A.
    Hildonen, M.
    Stemmerik, M. Godtfeldt
    Tumer, Z.
    Duno, M.
    Birkedal, U.
    Vissing, J.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S155 - S155
  • [39] Urinary titin in myotonic dystrophy type 1
    Varga, David
    Perecz, Brigitta
    Fulop, Krisztina
    Sipos, Andrea
    Janszky, Jozsef Vlagyimir
    Hajdu, Nandor
    Pal, Endre
    MUSCLE & NERVE, 2023, 68 (02) : 215 - 218
  • [40] Peripheral neuropathy in myotonic dystrophy type 1
    Hermans, Mieke C. E.
    Faber, Catharina G.
    Vanhoutte, Els K.
    Bakkers, Mayienne
    De Baets, Marc H.
    de Die-Smulders, Christine E. M.
    Merkies, Ingemar S. J.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 (01) : 24 - 29